Over the past two decades, brachytherapy has played an ever expanding role in the
definitive radiotherapy of prostate cancer. Brachytherapy surpasses external beam …

PURPOSE: A well-established body of literature supports the use of high-dose-rate (HDR)
brachytherapy as definitive treatment for localized prostate cancer. Most of the articles …

By placing radioactive sources directly into the cancer, brachytherapy allows delivery of a
highly conformal radiation dose to the prostate. Permanent seed brachytherapy is most …

Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …

BACKGROUND AND PURPOSE: High-dose-rate brachytherapy (HDR-BT) had been used
only in combination with external beam irradiation (EBI) until our previously reported first trial …

High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the
cancer with great sparing of surrounding organs at risk. Prostate cancer is thought to be …

Brachytherapy for prostate carcinoma has developed as either low dose rate permanent
implants or high dose rate afterloading. Both approaches offter unsurpassed dose …

PURPOSE: There are multiple treatment options for favorable-risk prostate cancer. High-
dose-rate (HDR) brachytherapy as a monotherapy is appealing, but its use is still …

Background and purpose A randomised phase-III trial compared external beam
radiotherapy (EBRT) alone with EBRT combined with high-dose-rate brachytherapy boost …

PURPOSE: To report our results in using high-dose-rate (HDR) brachytherapy for salvage of
local-only failure, after either external beam radiation or permanent seed implant …